{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T12:05:54Z","timestamp":1770725154183,"version":"3.49.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Janssen"},{"name":"Incyte"},{"DOI":"10.13039\/100011110","name":"UCB","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011110","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Lilly","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.jaad.2018.09.017","type":"journal-article","created":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T05:57:24Z","timestamp":1537423044000},"page":"823-828","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["A provider global assessment quality measure for clinical practice for inflammatory skin disorders"],"prefix":"10.1016","volume":"80","author":[{"given":"Alice","family":"Gottlieb","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Salame","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"April W.","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph F.","family":"Merola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvia","family":"Parra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junko","family":"Takeshita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suephy C.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Latella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Van Beek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2018.09.017_bib1","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMp1011024","article-title":"What is value in health care?","volume":"363","author":"Porter","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2018.09.017_bib2","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1001\/jamadermatol.2014.3514","article-title":"What dermatology still needs to create meaningful patient outcome measures","volume":"151","author":"Resneck","year":"2015","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2018.09.017_bib4","first-page":"641","article-title":"The Psoriatic Disease Payer Advisory Panel","volume":"15","author":"Merola","year":"2016","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2018.09.017_bib5","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jaad.2014.11.002","article-title":"The International Dermatology Outcome Measures Group: formation of patient-centered outcome measures in dermatology","volume":"72","author":"Gottlieb","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2018.09.017_bib6","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3109\/09546634.2013.865009","article-title":"The 5-point Investigator's Global Assessment (IGA) Scale: a modified tool for evaluating plaque psoriasis severity in clinical trials","volume":"26","author":"Langley","year":"2015","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jaad.2018.09.017_bib7","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1007\/s11136-013-0384-y","article-title":"Psychometric validation of the physician global assessment scale for assessing severity of psoriasis disease activity","volume":"22","author":"Cappelleri","year":"2013","journal-title":"Qual Life Res"},{"key":"10.1016\/j.jaad.2018.09.017_bib8","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jaad.2004.04.012","article-title":"Evaluating psoriasis with Psoriasis Area and Severity Index, Psoriasis Global Assessment, and Lattice System Physician's Global Assessment","volume":"51","author":"Langley","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2018.09.017_bib9","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jaad.2013.07.040","article-title":"Product of the Physician Global Assessment and body surface area: a simple static measure of psoriasis severity in a longitudinal cohort","volume":"69","author":"Walsh","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2018.09.017_bib10","first-page":"147","article-title":"Evaluation of the Physician Global Assessment and Body Surface Area Composite Tool for Assessing Psoriasis Response to Apremilast Therapy: results from ESTEEM 1 and ESTEEM 2","volume":"16","author":"Duffin","year":"2017","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2018.09.017_bib11","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1001\/archderm.1982.01650130027012","article-title":"Various parameters for grading acne vulgaris","volume":"118","author":"Allen","year":"1982","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2018.09.017_bib12","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1001\/archderm.139.11.1444","article-title":"A comparison of 15% azelaic acid gel and 0.75% metronidazole gel in the topical treatment of papulopustular rosacea: results of a randomized trial","volume":"139","author":"Elewski","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2018.09.017_bib13","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jaad.2003.09.032","article-title":"National Alopecia Areata Foundation. Alopecia areata investigational assessment guidelines. part II. National Alopecia Areata Foundation","volume":"51","author":"Olsen","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2018.09.017_bib14","doi-asserted-by":"crossref","first-page":"846","DOI":"10.7326\/0003-4819-157-12-201212180-00004","article-title":"Adalimumab for the treatment of moderate to severe hidradenitis suppurativa: a parallel randomized trial","volume":"157","author":"Kimball","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaad.2018.09.017_bib15","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jaad.2015.09.062","article-title":"A systematic review of Investigator Global Assessment (IGA) in atopic dermatitis (AD) trials: many options, no standards","volume":"74","author":"Futamura","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2018.09.017_bib16","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1287\/mnsc.9.3.458","article-title":"An experimental application of the Delphi Method to the use of experts","volume":"9","author":"Dalkey","year":"1963","journal-title":"Management Sci"},{"key":"10.1016\/j.jaad.2018.09.017_bib17","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1001\/jamadermatol.2016.5538","article-title":"Global skin disease morbidity and mortality: an update from the Global Burden of Disease Study 2013","volume":"153","author":"Karimkhani","year":"2017","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2018.09.017_bib18","doi-asserted-by":"crossref","first-page":"798","DOI":"10.2340\/16501977-1030","article-title":"How should we use the visual analogue scale (VAS) in rehabilitation outcomes? I: how much of what? The seductive VAS numbers are not true measures","volume":"44","author":"Franchignoni","year":"2012","journal-title":"J Rehabil Med"},{"key":"10.1016\/j.jaad.2018.09.017_bib19","doi-asserted-by":"crossref","first-page":"952","DOI":"10.3899\/jrheum.160113","article-title":"GRAPPA Trainees Symposium 2015: a report from the GRAPPA 2015 Annual Meeting","volume":"43","author":"Milliken","year":"2016","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2018.09.017_bib20","first-page":"30470","article-title":"How data can deliver for dermatology","volume":"21","author":"Abuabara","year":"2018","journal-title":"J Am Acad Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962218325982?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962218325982?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:47:41Z","timestamp":1759272461000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962218325982"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S0190962218325982"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2018.09.017","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A provider global assessment quality measure for clinical practice for inflammatory skin disorders","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2018.09.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}